Sai Sree Teja Kethamreddy

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech

AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by lipids, metabolites and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GD™, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer.

NCM is a specialized investment manager focused on generational founders and companies across artificial intelligence, software and infrastructure frontiers. We target investments in global developed markets, providing stable rule of law, developed technology & startup ecosystems, liquid capital markets and significant investment activity. NCM is licensed and regulated by the Monetary Authority of Singapore (MAS) under the Venture Capital Fund Management regime.

Nexxus Capital was a cross-border consulting boutique focused on event-driven strategic consulting services that engaged with clients in pivotal moments, including M&A, Growth Strategy and Special Situations. The company worked across a variety of sectors, from fast-growing tech-enabled companies to mature industrials and leading telecom players. Nexxus Capital is deregistered and currently does not have active operations in Hong Kong anymore.

VU Venture Partners is a multi-stage venture capital fund focusing on Consumer, Enterprise, FinTech, Frontier, Healthcare, and PropTech

AOA Dx is leading a revolutionary breakthrough in early-stage cancer detection, leveraging the transformative potential of AI and our proprietary biomarker technology. At the heart of this innovation is our GlycoLocate platform, a multi-omics approach powered by lipids, metabolites and proteins. This platform is setting a new gold standard in the quest for life-saving early cancer diagnostics. We are now advancing AKRIVIS GD™, a cutting-edge liquid biopsy test designed specifically for the early detection of ovarian cancer.

The Adventure Club NITC, better known as TAC, is one of the prominent clubs of National Institute of Technology, Calicut. We have come a long way and has conducted many enthralling events like Road to Tathva, Adrenaline etc. Even during the tough pandemic situation, the club overcame the challenges by conducting various interesting online events like Fan Fight and Country Bluff where the participants had a great and wonderful time, evident from the overwhelming responses received. The club maintains its energetic and zestful nature always and throughout its journey. Come and venture out into the world of adventure and get lost into the realm of TAC.